Brainsway Ltd ADRBWAY
Price$12.60Intrinsic value$6.7047% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $41M+29.0% YoYTTM through 30 Jun 2025
Net Income $2.9MTTM through 30 Jun 2025
Free Cash Flow $8.1MTTM through 30 Jun 2025

Margins

Current
Gross Margin75.0%
EBITDA Margin3.9%
Operating Margin8.3%
Net Margin7.1%

Returns

4.3%ROE
6.4%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio3.83x
Net Debt-$68Mnet cash position
Cash & Equivalents$67.9M

Quality Metrics

Piotroski F-Score5 / 9
FCF Margin19.7%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'18'19'20'21'22'23'24
FY2024: $41M
Diluted EPS
'18'19'20'21'22'23'24
FY2024: $0.09

Dividend

No dividend

Capital Allocation

Capex Intensity5.5%

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.